title: [A sepsis case caused by a rare opportunistic pathogen: Bacillus pumilus].
abstract: The high prevalence of Bacillus species in nature and the detection of these bacteria as contaminant in cultures may lead diagnostic dilemma, however they should still be considered as a pathogen particularly in case of repeated positive cultures from patients with risk factors. Bacillus pumilus is a bacteria, though rarely, been reported as the causative agent of various infections such as sepsis, endocarditis, skin infections and food poisoning in human. In this report, a sepsis case in an immunocompetent patient caused by B.pumilus was presented. A 38-year-old female patient was admitted to emergency service of our hospital with the complaints of headache, dizziness and diarrhea. She had not any risk factors except a history of heart valve replacement operation two years ago. In physical examination, she had abdominal retention, high fever and hypotension, together with the high levels of sedimentation rate (ESR) and C-reactive protein (CRP). The patient was hospitalized with the preliminary diagnosis of sepsis. Three sets of blood samples at two different periods were taken for the culture. All blood culture vials had a positive signal at the second day of incubation in BD BACTEC™ 9050 system, therefore subcultures were performed in sheep blood agar, chocolate agar and MacConkey agar, and incubated in aerobic and anaerobic conditions. Beta-haemolytic, gray-colored large colonies were isolated from anaerobic culture at the end of 18-24 hours incubation, and Gram staining from colonies showed gram-positive rods. The isolate was identified as B.pumilus with 99% accuracy rate by using BD Phoenix™ 100 identification system. This result was also confirmed by MALDI-TOF based VITEK® MS system and 16S rRNA sequencing by Illumina MiSeq® platform. Antibiotic susceptibility test performed by BD Phoenix™ 100 system and the isolate was found to be resistant against penicillin, while it was susceptible to vancomycin, erythromycin, clindamycin, levofloxacin, and trimethoprim-sulfamethoxazole. Initial treatment of patient was started with intravenous ceftriaxone and metronidazole empirically. Hypotension and fever returned to normal levels at the second and third days of the treatment, respectively. Metronidazole treatment was stopped at seventh day, and treatment was completed to 14 day with ceftriaxone alone. At the end of the treatment course, general condition of the patient was completely good, ESR and CRP were also decreased to normal levels. In conclusion, although most of the reported bloodstream infections that are caused by B.pumilus are intravascular catheter-related, artificial heart valves should also be considered as a risk factor even though vegetation was not detected in our patient.
authors.affiliation: Istanbul Kemerburgaz University Faculty of Medicine, Department of Medical Microbiology, Istanbul, Turkey. baris.borsa@kemerburgaz.edu.tr.
authors.forename: Barış Ata
authors.initials: BA
authors.lastname: Borsa
authors.forename: Mehmet Ersoy
authors.initials: ME
authors.lastname: Aldağ
authors.forename: Birsen
authors.initials: B
authors.lastname: Tunalı
authors.forename: Uğur
authors.initials: U
authors.lastname: Dinç
authors.forename: Zeynep
authors.initials: Z
authors.lastname: Güngördü Dalar
authors.forename: Veli Cengiz
authors.initials: VC
authors.lastname: Özalp
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016863:Bacillaceae Infections / Q000188:drug therapy / Q000382:microbiology*; D000069979:Bacillus pumilus / Q000187:drug effects / Q000472:pathogenicity*; D001799:Blood Sedimentation; D002097:C-Reactive Protein / Q000032:analysis; D002443:Ceftriaxone / Q000627:therapeutic use; D005260:Female; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D009894:Opportunistic Infections / Q000188:drug therapy / Q000382:microbiology*; D018805:Sepsis / Q000188:drug therapy / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents; D008795:Metronidazole; D002443:Ceftriaxone; D002097:C-Reactive Protein